HISTORICAL FACTS: 2 - The Untold Story

Johnson & Johnson Halts Production Of Its COVID-19 Vaccine: NYT

Johnson & Johnson (NYSE: JNJ) quietly shut down the only plant making usable batches of its COVID-19 vaccine, the 

Benzinga · Feb 8, 2022

J&J may be forced to stop selling talc in UK as cancer court cases continue

"Various studies have shown a link between using talcum powder between the legs and ovarian cancer."

Wales Online · Feb 6, 2022

Johnson & Johnson faces push to force global ban on talc baby powder sales

Move to hold shareholder vote follows withdrawal of product in US and Canada and lawsuits alleging link to cancer cases

The Guardian - UK · Feb 6, 2022

Native American tribes reach $590M opioid settlement with Johnson & Johnson and distributors

It's the largest opioid settlement for Native Americans.

Axios · Feb 2, 2022

Johnson & Johnson Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga · Jan 31, 2022

This Is What Whales Are Betting On Johnson & Johnson

Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga · Jan 25, 2022

Mid-Morning Market Update: Markets Open Lower; Johnson & Johnson Sales Miss Views

Following the market opening Tuesday, the Dow traded down 1.79% to 33,748.82 while the NASDAQ fell 2.56% to 13,499.97. The S&P also fell, dropping, 2.59% to 13,496.29.

Benzinga · Jan 25, 2022

Johnson & Johnson's FY21 COVID-19 Vaccine Sales Below Expectations

Johnson & Johnson (NYSE: JNJ) 

Benzinga · Jan 25, 2022

Johnson & Johnson: Q4 Earnings Insights

  Johnson & Johnson (NYSE:JNJ) reported its Q4 earnings results on Tuesday, January 25, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga · Jan 25, 2022

5 Stocks To Watch For January 25, 2022

Some of the stocks that may grab investor focus today are: Wall Street expects Johnson & Johnson (NYSE: JNJ) to report quarterly earnings at $2.12 per share on revenue of $25.29 billion before the opening bell. Johnson & Johnson shares fell 0.3% to $162.50 in after-hours trading.

Benzinga · Jan 25, 2022